Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA.

Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Xukang Medical Technology (Suzhou) Co., Ltd., established on 2015-04-03, Business scope includes technological development of medical technology and biotechnology,Technology Promotion,technical consulting,Technical Services,technology transfer;genetic analysis,Health Management Consulting;Research and development of biological reagents;Sales of biological reagents for laboratory use;Production and sales of medical supplies and equipment;Sales of laboratory equipment;computer software development;computer,Sales of software and auxiliary equipment;Self-operated and agent import and export business of various commodities and technologies(Excluding commodity technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Produces grain mill products

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Shenzhen Sinobioway Xinpeng Biomedicine Co., Ltd. engages in the research, development, production, and marketing of biotechnology drugs. The company was founded on December 18, 1992 and is headquartered in Shenzhen, China.

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Cook Biotech, Inc., a subsidiary of Cook Group, Inc., is a company headquartered in West Lafayette, IN, that develops and manufactures medical products for tissue repair and regenerative medicine applications. The firm was founded in 1963.\nThe company says this about itself: Cook Biotech Inc. develops and manufactures medical products for tissue repair and regenerative medicine applications using proprietary extracellular matrix (ECM) technologies and processes. Cook Biotech products are marketed and distributed under several brand names, including Biodesign® and OASIS®. Cook Biotech collaborates with partners and distributors, including AxoGen Inc., Aziyo Biologics, Cook Medical Inc., Cormatrix, Katena Products Inc., Keystone Dental Inc., and Smith & Nephew Inc., to develop new products and provide technical support. Cook Biotech was established in 1995 and is affiliated with Cook Medical Holdings in Bloomington, Indiana. It is located in the Purdue Research Park in West Lafayette, Indiana.

Changsha Aotu Biotechnology Co., Ltd., established on 2012-08-14, Business scope includes biotechnology extension services;consult,communication service,transfer service;Medical Supplies,Sales of Class I Medical Devices;Research and development of a class of medical devices;Optical Instrument Manufacturing;Medical Device Technology Development;Medical device technical consultation,communication service;Medical device technology transfer service;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)

Hunan Very Beautiful Health Technology Co., Ltd., established on 2019-02-22, Business scope includes health management;Medical device technology promotion service;Medical Research and Experimental Development;research and development,Incubation and Transformation;Healthy food,cosmetic,hygiene products,disinfectant,Class I medical device,Research and development of health products;Technical research and development of pharmaceutical excipients,consult,technology transfer;Health products,Health Supplies,disinfectant,Medical Laboratory Equipment and Appliances,daily necessities,Electrical Equipment,Electronics and Accessories,Sales of electronic instruments;Cosmetics and hygiene products,Class I medical device,Sanitation products,Retailing of daily necessities;General Instrument Sales;Biotechnology Extension Services;beauty consultation;Health and Wellness Consulting(Does not contain medical diagnoses);Nutrition and Health Consulting Services;Instrument wholesale.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Dainichiseika Color & Chemicals Mfg. Co., Ltd. engages in the manufacture and sale of inorganic and organic pigments, printing inks, coloring agents for plastics and synthetic fibers, printing agents for textile, synthetic resin and high polymer products, electronics related products, biochemical products, and spectrophotometers. Its operations are carried out through the following segments: Chemical Products, Chemicals, High Polymers, Print Integrated Systems, and Others. The Chemical Products segment provides organic and inorganic pigments, coloring agents, and information record-related materials. The Chemicals segment offers synthetic resin colorants and compounds, and various coating materials. The High Polymers segment deals with high-polymer and natural polymer products. The Print Integrated Systems segment involves printing inks and related products and services. The Others segment includes resale of raw materials, lease of real estate to group companies, and finance services. The company was founded on October 16, 1931 and is headquartered in Tokyo, Japan.

CorMatrix Cardiovascular is a privately held medical device company that is dedicated to developing and delivering innovative biomaterial devices that harness the body’s own innate ability to repair damaged heart tissue. The company is currently researching, developing, and commercializing a platform technology, known as CorMatrix ECM, for a variety of cardiovascular indications. Incorporated in December of 2001, CorMatrix was co-founded by David Camp, an entrepreneurial executive in the cardiovascular medical device field, and Robert G. Matheny, MD, a cardiothoracic surgeon and co-inventor on several patents related to extracellular matrix (ECM) technology. Dr. Matheny’s interest and experience with these unique materials began at Purdue University in the 1990s while he was a private practice cardiac surgeon in Indianapolis. Realizing the potential of extracellular matrix materials for cardiovascular surgery, he further increased his study and preclinical work in matrix materials and tissue repair.

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Rhone Poulenc Rorer, a subsidiary of Solvay SA, is a French company that manufactures and distributs pharmaceutical products.

Pentax (ペンタックス Pentakkusu) is a brand name used primarily by Japanese multinational imaging and electronics company Ricoh for cameras, sport optics (including binoculars and rifle scopes), and CCTV optics. The brand is also used by Hoya Corporation for medical products & services, TI Asahi for surveying instruments, and Seiko Optical Products for certain optical lenses.

Bach Pharma, Inc. is a private company headquartered in North Andover, MA, that manufactures pharmaceutical products. Kelly Blackburn has been the CEO since 2016.\nThe company says this about itself: Bach Pharma, Inc. (BACH), a privately held research and development pharmaceutical company, directs the development of therapies for degenerative neurological illnesses. The company's lead candidate GVT is a novel cytoprotective agent that has powerful anti-oxidant and anti-inflammatory properties, which research has shown can reverse oxidative stress, restore intracellular redox homeostasis and quell inflammation. Due to its strong safety profile along with its ability to cross the retinal and the blood-brain barriers and enter cells of the central nervous system, GVT has the potential to treat serious diseases of the central nervous and immune systems and dramatically reduce the cost of global health care.

Bionet Corp. engages in the businesses of cell therapy, regenerative medicine and medical big data. Its services and products include cell storage & application services, prenatal testing, and biotechnology medical beauty care products. The company was founded on August 17, 2000 and is headquartered in Taipei, Taiwan.